A phase I study evaluating the role of the anti-epidermal growth factor receptor (EGFR) antibody cetuximab as a radiosensitizer with chemoradiation for locally advanced pancreatic cancer

被引：0
作者：
J. P. Arnoletti
A. Frolov
M. Eloubeidi
K. Keene
J. Posey
T. Wood
Edward Greeno
N. Jhala
S. Varadarajulu
S. Russo
J. Christein
R. Oster
D. J. Buchsbaum
S. M. Vickers
机构：
[1] University of Alabama at Birmingham,Department of Surgery
[2] University of Alabama at Birmingham,Department of Gastroenterology
[3] University of Alabama at Birmingham,Department of Radiation Oncology
[4] University of Alabama at Birmingham,Department of Medical Oncology
[5] University of Minnesota,Division of Hematology, Oncology and Transplantation
[6] University of Alabama at Birmingham,Department of Pathology
[7] East Carolina University,Department of Radiation Oncology
[8] University of Alabama at Birmingham,Department of Biostatistics
[9] University of Minnesota, Surgery Department
来源：
Cancer Chemotherapy and Pharmacology | 2011年 / 67卷
关键词：
Cetuximab; Gemcitabine; Radiation therapy; Pancreatic cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：891 / 897
页数：6
相关论文
共 50 条
  • [41] Effect of risk factors for acneiform rash induced by anti-epidermal growth factor receptor antibody drugs on survival: a retrospective observational study
    Takahashi, Hiroaki
    Yaegashi, Yukiko
    Saito, Yoko
    Nihei, Satoru
    Tairabune, Tomohiko
    Ujiie, Haruki
    Asaka, Junichi
    Kudo, Kenzo
    JOURNAL OF PHARMACEUTICAL HEALTH CARE AND SCIENCES, 2022, 8 (01)
  • [42] Risk Factor Analysis for Anti-epidermal Growth Factor Receptor Monoclonal Antibody-induced Problematic Skin Toxicities in Patients With Liver Metastatic Colorectal Cancer
    Saito, Yoshitaka
    Uchiyama, Kazuki
    Takekuma, Yoh
    Komatsu, Yoshito
    Sugawara, Mitsuru
    IN VIVO, 2024, 38 (05): : 2390 - 2398
  • [43] PD-L1 Expression in Unresectable Locally Advanced or Metastatic Skin Squamous Cell Carcinoma Treated with Anti-Epidermal Growth Factor Receptor Agents
    Cavalieri, Stefano
    Perrone, Federica
    Milione, Massimo
    Bianco, Alba
    Alfieri, Salvatore
    Locati, Laura D.
    Bergamini, Cristiana
    Resteghini, Carlo
    Galbiati, Donata
    Platini, Francesca
    Licitra, Lisa
    Bossi, Paolo
    ONCOLOGY, 2019, 97 (02) : 112 - 118
  • [44] Risk factor analysis for anti-epidermal growth factor receptor monoclonal antibody–induced skin toxicities in real-world metastatic colorectal cancer treatment
    Yoshitaka Saito
    Kazuki Uchiyama
    Yoh Takekuma
    Yoshito Komatsu
    Mitsuru Sugawara
    Supportive Care in Cancer, 2023, 31
  • [45] Role of First-Line Anti-Epidermal Growth Factor Receptor Therapy Compared With Anti-Vascular Endothelial Growth Factor Therapy in Advanced Colorectal Cancer: A Meta-Analysis of Randomized Clinical Trials
    Khattak, Muhammad A.
    Martin, Hilary
    Davidson, Andrew
    Phillips, Michael
    CLINICAL COLORECTAL CANCER, 2015, 14 (02) : 81 - 90
  • [46] Restoring apoptosis in pancreatic cancer cells by targeting the nuclear factor-κB signaling pathway with the anti-epidermal growth factor antibody IMC-C225
    Sclabas, GM
    Fujioka, S
    Schmidt, C
    Fan, Z
    Evans, DB
    Chiao, PJ
    JOURNAL OF GASTROINTESTINAL SURGERY, 2003, 7 (01) : 37 - 43
  • [47] Restoring apoptosis in pancreatic cancer cells by targeting the nuclear factor-κb signaling pathway with the anti-epidermal growth factor antibody IMC-C225
    Guido M. Sclabas
    Shuichi Fujioka
    Christian Schmidt
    Zhen Fan
    Douglas B. Evans
    Paul J. Chiao
    Journal of Gastrointestinal Surgery, 2003, 7 : 37 - 43
  • [48] Epidermal growth factor receptor (EGFR) pathway polymorphisms as predictive markers of cetuximab toxicity in locally advanced head and neck squamous cell carcinoma (HNSCC) in a Spanish population
    Fernandez-Mateos, J.
    Seijas-Tamayo, R.
    Mesia, R.
    Taberna, M.
    Pastor Borgonon, M.
    Perez-Ruiz, E.
    Klain, J. C. Adansa
    Vazquez Fernandez, S.
    del Barco Morillo, E.
    Lozano, A.
    Gonzalez Sarmiento, R.
    Cruz-Hernandez, J. J.
    ORAL ONCOLOGY, 2016, 63 : 38 - 43
  • [49] A randomised, open label phase III trial with nimotuzumab, an anti-epidermal growth factor receptor monoclonal antibody in the treatment of newly diagnosed adult glioblastoma
    Westphal, Manfred
    Heese, Oliver
    Steinbach, Joachim P.
    Schnell, Oliver
    Schackert, Gabriele
    Mehdorn, Maximilian
    Schulz, Dirk
    Simon, Matthias
    Schlegel, Uwe
    Senft, Christian
    Geletneky, Karsten
    Braun, Christian
    Hartung, Joachim G.
    Reuter, Dirk
    Metz, Monika Warmuth
    Bach, Ferdinand
    Pietsch, Torsten
    EUROPEAN JOURNAL OF CANCER, 2015, 51 (04) : 522 - 532
  • [50] Systemic Therapy for Advanced or Metastatic Colorectal Cancer: National Comprehensive Cancer Network Guidelines for Combining Anti-Vascular Endothelial Growth Factor and Anti-Epidermal Growth Factor Receptor Monoclonal Antibodies with Chemotherapy
    Engstrom, Paul F.
    PHARMACOTHERAPY, 2008, 28 (11): : 18S - 22S
12345